Onco-Innovations Limited (CVE:ONCO) | Finanzwire

Basculer en Français

11115	Companies
244640	Keywords
172670	Articles
131843	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 06/27/2026 at 00:05, 3 months 5 days ago

Onco-Innovations Initiates Metabolic Studies for ONC010

Drug Development Preclinical Studies Onco-Innovations ONC010 Liver Metabolism
PRESS RELEASE

published on 06/27/2026 at 00:00, 3 months 5 days ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Onco-Innovations announces hepatocyte and liver microsome metabolism studies for ONC010, its lead nanoparticle-formulated PNKP inhibitor, to support future toxicology studies and regulatory submissions

Metabolism Onco-Innovations ONC010 Hepatocyte Liver Microsome
BRIEF

published on 06/24/2026 at 00:05, 3 months 8 days ago

Onco-Innovations Partners with Nanosoft for ONC010 Development

Drug Delivery Onco-Innovations ONC010 Nanosoft Polymers Polymer Development
PRESS RELEASE

published on 06/24/2026 at 00:00, 3 months 8 days ago

Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Onco-Innovations partners with Nanosoft Polymers to enhance development of ONC010, a PNKP inhibitor, through polymer process development and formulation optimization

Onco-Innovations PNKP Inhibitor ONC010 Nanosoft Polymers Polymer Engineering
BRIEF

published on 06/20/2026 at 01:05, 3 months 12 days ago

Onco-Innovations Announces Non-Brokered Private Placement

Private Placement Warrants Clinical Development Onco-Innovations Financing Exemption
PRESS RELEASE

published on 06/20/2026 at 01:00, 3 months 12 days ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Onco-Innovations Limited announces non-brokered private placement to advance cancer research and treatment. Units offered for CAD$0.7392 per Unit with gross proceeds of CAD$5,000,000

Private Placement Canadian Securities Laws Clinical Development Cancer Research Onco-Innovations Limited
BRIEF

published on 06/20/2026 at 00:05, 3 months 12 days ago

Onco-Innovations Achieves Key Manufacturing Milestone and Appoints New CFO

New CFO Onco-Innovations ONC010 300g Scale-up API Purity
PRESS RELEASE

published on 06/20/2026 at 00:00, 3 months 12 days ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Onco-Innovations completes successful 300g scale-up batch of A83B4C63, achieving 99.3% purity for API under ONC010 PNKP Inhibitor Technology. Dave Antony appointed as CFO

CFO Manufacturing Milestone Onco-Innovations Dave Antony Scale-up Batch
BRIEF

published on 06/17/2026 at 00:05, 3 months 15 days ago

Onco-Innovations and Kuano Complete Collaborative Project on PNKP Inhibitor Technology

Drug Discovery Onco-Innovations PNKP Inhibitor Quantum-based Platform AI-enabled Discovery
PRESS RELEASE

published on 06/17/2026 at 00:00, 3 months 15 days ago

Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization
Onco-Innovations announces successful completion of a pilot project with Kuano Ltd., advancing its PNKP Inhibitor Technology through AI and quantum-based computational approaches

AI-enabled Onco-Innovations Kuano Ltd. PNKP Inhibitor Technology Quantum-based

Accesswire

Published on 10/02/2026 at 04:15, 2 hours 15 minutes ago

Torq Completes $529,000 Debt Settlement
Published on 10/02/2026 at 00:35, 5 hours 55 minutes ago

Medicure Announces Grant of Stock Options
Published on 10/02/2026 at 00:30, 6 hours ago

Immutable Holdings Provides Corporate Update
Published on 10/01/2026 at 23:05, 7 hours 25 minutes ago

Vox Royalty Expands Revolving Credit Facility Up to $150 Million and Strengthens Leadership Team
Published on 10/01/2026 at 22:00, 8 hours 30 minutes ago

Golden Minerals Company Announces New Management Appointments and Resignation of Mr. Pablo Castanos

View all ACCESSWIRE

EQS Group

Published on 10/02/2026 at 06:05, 25 minutes ago

19.3% Weight Loss at Week 48: Phase Ⅲ Data of Olatorepatide, Hansoh's Dual‑Biased GLP‑1/GIP Agonist, Presented at EASD
Published on 10/02/2026 at 04:05, 2 hours 25 minutes ago

Angel Aligner Upgrades Torque Ridges to "Pressure Points" in Europe
Published on 10/02/2026 at 00:01, 6 hours 29 minutes ago

PolyPeptide publishes the invitation to its extraordinary general meeting of shareholders on 26 October 2026
Published on 10/01/2026 at 23:15, 7 hours 15 minutes ago

CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies
Published on 10/01/2026 at 20:45, 9 hours 45 minutes ago

Ditto Named a Product Leader in KuppingerCole Analysts Leadership Compass for Identity Verification

Les Echos

Published on 10/01/2026 at 19:00, 11 hours 30 minutes ago

AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 11 hours 49 minutes ago

Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 12 hours 25 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 10/01/2026 at 18:00, 12 hours 29 minutes ago

Saint-Gobain completes the acquisition of Xypex (North America), a leader in high value-added waterproofing solutions
Published on 10/01/2026 at 17:55, 12 hours 35 minutes ago

Disclosure of transactions in own shares from September 28 to September 30, 2026

View all LES ECHOS COMFI WIRE